{"name":"Reven Pharmaceuticals, Inc.","slug":"reven-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxPZlFCRE0tR09IcFR6RXFhYmRTeTcyRTVrT3ByNHUzRXN4VFFBZExzMGtmNkNwa09NX0VFd3EzaUhSVmZpSTJkRFlqOFBuYVNpWHNBLWE3WjlkMjM2bWVhYS1zYTllbnRHb1JKV0l5ZlQzTEFaSmUzYW5pS2NiRkowZVZLU183Z0dsM2psTjZhVG5UNDdBTzM4?oc=5","date":"2026-02-14","type":"pipeline","source":"The Motley Fool","summary":"Best Pharmaceutical Stocks for 2026 and How to Invest in Them - The Motley Fool","headline":"Best Pharmaceutical Stocks for 2026 and How to Invest in Them","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxPRzdGMDR5WnZkNk9wMnRNUldFRHZocjVTaHRIXzh2OXhSX3h1VmJYZWZ0M2JhaE05NDItRkYtbWR3WTdpajFJUk01MERObGZFQmE3R3ZpWnhsY0t5bnJZOTJxVEJvS05jem1XbUhzN1lzWGVDUVdLVnY5NlRXSFNQU2NvTlc1eG1aZGl1N2pTdWZOQVFLLXdock15aEtwQ1MxYnlIVXRIVUdGWlQ5?oc=5","date":"2025-05-14","type":"pipeline","source":"Bloomberg Law News","summary":"Appeals Panel Wary of Pharma Firm’s Bid to Lift SEC Asset Freeze - Bloomberg Law News","headline":"Appeals Panel Wary of Pharma Firm’s Bid to Lift SEC Asset Freeze","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOb1ZpUk1GdTFmQ1JWNGxuY1FRT20zT3ExbEZiUzd3dERfVW4tUnJjdUR6OV9GLVBxaFhWT2VpRmFUQUNUcmRPOThva2dCcWJGYm04Sk53NDNVTnlqcWloV2tVTkZoa0tYamhMV0lSd19EUVllcU5vcEZyTzhLbGF0T2FIdnRPT0ExU3B1cEgyaW5VUmgwUmFETFhCN3ZJMVFwQzRNTkFTM1RqMi05S2V30gFaQVVfeXFMUGxjdVF0YWo0Yi1PMnFBZlE1b01qOW0zdUhQaGJXNFVvalZsUExaX3c0enRJOVNqM01HMjB3QnNkVWdHYXNrSlBxU1FtbWxKbUtpNFdSVmEycW9n?oc=5","date":"2025-05-14","type":"patent","source":"MLex","summary":"Impact of asset freeze on patent portfolio a non-issue for US panel - MLex","headline":"Impact of asset freeze on patent portfolio a non-issue for US panel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxPVDVCd3ZQbkNqUkFiMm1URFZPRVVtNV8yaVZDdDdvUk40akhjN3pFbnpTazg3R3pacHBmbjYzem5oVGlYX1F4Zml2ZS1NS2k4dEpLX21WTC00VGFpU2NYejdNUEJCaHpSdmNwNzJKazBCNkc0UElMRDcxVXFGZWMtNW45TTYxY1FtNV9UUmFHV2JkaEJRSy0yT1hhcmJMS29ZRFczcVltclpFRThwZjlyR1RIU01jNlBkZnlHVDdEb1pSS0pLTlRsaHNNMWVXR0lueS0zenUxLXc3UQ?oc=5","date":"2024-06-13","type":"pipeline","source":"prnewswire.com","summary":"Global Artificial Blood Vessels Market to Surpass 3 Billion Mark by 2030 | DelveInsight - prnewswire.com","headline":"Global Artificial Blood Vessels Market to Surpass 3 Billion Mark by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxNcnlUN1F6MmhTNzlxV3pQWm1GNTdCeTRUN0dJZzRwNXdTZjZaMmtMd0c3ZTF2NjNQNkhQNEp4ZTJHWGx1d0FJRk9MUEt6bHdZdlZUR0NZYXNibkV5aU13Tk9JVkhJR1Zxc0ZjOFRkNm92UWhKckVUNzlpOV8wWWFuS1hKVlJtc0Z3TGpIMWlMUURySzZvZVV1YnRYcXdoc2EzWGxYLVR3UVlVR3BOT1pFOWJTdFJaVS02OENTSUVTT1NMYXlLZWpYS3hzUURQNUtCWWdUTGY5cWp4WmR5dm5kZTFRSGNlRlNOMGpEa3JsQURWVGhQNXc4TnRHaWM?oc=5","date":"2024-05-02","type":"pipeline","source":"prnewswire.com","summary":"Global Angioplasty Balloons and Stents Market to Exhibit Substantial Growth at a CAGR of ~4% by 2030 | DelveInsight - prnewswire.com","headline":"Global Angioplasty Balloons and Stents Market to Exhibit Substantial Growth at a CAGR of ~4% by 2030 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPNVJUeEptc1hTRVk5TXJFbGJYMkZ6ekhlVGV5cGVUd1BLb2VLYXgwUzNrRE5nODJDWTJ4N1M5LUNhU19ycDRNRndvc19zRWJIZnQyUWpzNWFubEFoU0FlNUJrZ2RYck9QVlRWZHpDOFliTUxaalhqZktObHhObTd1LXpn?oc=5","date":"2024-03-30","type":"pipeline","source":"USA Herald","summary":"SEC Wins Extended Asset Freeze Against Reven Holdings - USA Herald","headline":"SEC Wins Extended Asset Freeze Against Reven Holdings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAJBVV95cUxOTE5kNXU1WEs4VFVQclpCZ3EwWVdLV0tSUFlXcTVZcVRLb3JnSTVmdzdKR0l2VjRVMUFmazMyZFVLLVduU21UNkhLbFJObWt6MWIyc29CTWc4Qzk4djRMVWkwcWEyNU1LelZWY2RXWmJFdk9taWJkWGJrMkhBRURyTldZVnliYWpLektsdXlzUzg2NlJkbklTUXo5VHAwSy1pdzFyQ00tS3VRSlZINFZsNjJpaXZqUXpoMFNpeS1pZUlzVjZFTWl1eDZKTXJodS1MQ0ljRi1UTE5va0Z0dGhEeWxqb1FDVS1FNkU1YzBuQ1Z3aXZtSHdKVXhGenBPLXlsZEJsYXZpQ2stbDM1bmpidDNvcVVxZWY5?oc=5","date":"2023-01-22","type":"pipeline","source":"InForum","summary":"Former Fargo executive once embroiled in financial woes now accused of defrauding investors - InForum","headline":"Former Fargo executive once embroiled in financial woes now accused of defrauding investors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQWkNhN0tLZW5zbEdBTzdJVHhJeHhjUFdvVVlPYjJiMi1NX1JseHRma0U0OFNDdmVMX1NNcDFGZUNhMXNQRFJ3MEdWclB4dmRMRG5WTkRWejYyT0MxQkxzN2hldk5qaWliaExZMVJFY1h4a3ZhQUxHSkh4My1ZTk55akVHWHRQY1Y0S0Y2UUk2bWJjTXdIX0xoU3YwNUItNTFr?oc=5","date":"2022-03-23","type":"pipeline","source":"Business Insider","summary":"Insider identified 13 drug companies that are in a dangerous financial position and struggling to survive through 2022 - Business Insider","headline":"Insider identified 13 drug companies that are in a dangerous financial position and struggling to survive through 2022","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQV01fWWdfZmNCODBfMXVyaW9aQVA1aXl1b0FjVEx5MVRSQVotQXU2WWFxMnl5aTg5Y0hCVzRMNDJ0b0NmT2lMUWhsOW1KZUV3alo5RjNiSkpSUHlJOElXWUpHakNkcG05S3dDclJoNWNHcVlGaVBMYUszN1JnRTd0SWM4OVBYUG91?oc=5","date":"2021-05-21","type":"pipeline","source":"OpenSecrets","summary":"Pharmaceuticals/Health Products Lobbying Profile - OpenSecrets","headline":"Pharmaceuticals/Health Products Lobbying Profile","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}